|
|
||||||||||
|
J Am Coll Cardiol, 2005; 45:14-18, doi:10.1016/j.jacc.2004.09.050 © 2005 by the American College of Cardiology Foundation |


* Cardiac Surgery
Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts
Manuscript received July 22, 2004; revised manuscript received September 18, 2004, accepted September 21, 2004.
* Reprint requests and correspondence: Dr. John G. Byrne, Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-8815 (Email: john.byrne{at}vanderbilt.edu).
Presented at the Annual Scientific Session of the American College of Cardiology, March 7 to 10, 2004, New Orleans, Louisiana.
OBJECTIVES: The goal of this study was to determine if a "hybrid" approach to the treatment of complex combined coronary and valve disease is superior to the results predicted by a Society of Thoracic Surgeons' (STS) algorithm with conventional coronary artery bypass graft (CABG)/valve surgery in high-risk patients.
BACKGROUND: With advancements in percutaneous coronary interventions (PCIs), some patients requiring coronary revascularization and valve surgery may benefit from a hybrid approach involving initial planned PCI followed by valve surgery, rather than conventional CABG/valve surgery.
METHODS: We retrospectively analyzed 26 consecutive patients with coronary artery and valve disease who underwent planned initial PCI followed by valve surgery during the same hospital stay between September 1997 and August 2003. We calculated the predicted mortality at the time of PCI and compared it with the observed mortality.
RESULTS: There were 12 male and 14 female patients with a median age of 72 years (range 53 to 91 years). Balloon angioplasty was performed in all patients, followed by stenting in 22 (85%) patients. Within a median of 5 days (range 0 to 14 days), 15 patients (58%) underwent primary and 11 patients (42%) underwent re-operative valve surgery. Operative mortality was 1 of 26 patients (3.8%), dramatically lower than the STS-predicted mortality of 22%. Median blood loss was 900 ml, and 22 patients (85%) required blood transfusions. Survival at 1, 3, and 5 years was 78%, 56%, and 44%, respectively.
CONCLUSIONS: Hybrid initial PCI followed by staged valve surgery represents an excellent alternative to conventional CABG/valve surgery in some high-risk patients, particularly those who present in shock after myocardial infarction. Lower mortality rates come at the cost of more bleeding and transfusion requirements.
| |||||||
This article has been cited by other articles:
![]() |
R. Umakanthan, M. Leacche, M. R. Petracek, S. Kumar, N. V. Solenkova, C. A. Kaiser, J. P. Greelish, J. M. Balaguer, R. M. Ahmad, S. K. Ball, et al. Safety of minimally invasive mitral valve surgery without aortic cross-clamp. Ann. Thorac. Surg., May 1, 2008; 85(5): 1544 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Filsoufi, P. B. Rahmanian, J. G. Castillo, J. Chikwe, and D. H. Adams Predictors and Early and Late Outcomes of Respiratory Failure in Contemporary Cardiac Surgery Chest, March 1, 2008; 133(3): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Greelish, R. M. Ahmad, J. M. Balaguer, M. R. Petracek, and J. G. Byrne Reoperative Valve Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 1159 - 1174. [Full Text] |
||||
![]() |
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur. Heart J., January 26, 2007; (2007) ehl428v1. [Full Text] [PDF] |
||||
![]() |
M. Pocar, A. Moneta, R. Mattioli, A. Assaghi, and F. Donatelli Benefits of Staged Carotid Stenting Before Cardiac Surgery: a Randomized Trial Is Unwise Stroke, September 1, 2006; 37(9): 2208 - 2208. [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., January 17, 2006; 47(2): 427 - 439. [Full Text] [PDF] |
||||
![]() |
J. P. Greelish, S. S. Eagle, D. X. Zhao, R. J. Deegan, M. H. Crenshaw, J. M. Balaguer, R. M. Ahmad, and J. G. Byrne Management of new-onset mitral regurgitation with intraoperative angiography and intraoperative percutaneous coronary intervention J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 239 - 240. [Full Text] [PDF] |
||||
![]() |
S. Maltais, D. Bouchard, and L. P. Perrault Concomitant Surgical Myocardial Revascularization Is Still the Gold Standard for Combined Valvular and Coronary Heart Disease J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1782 - 1783. [Full Text] [PDF] |
||||
![]() |
J. G. Byrne Reply J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1783 - 1783. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |